L型氨基酸转运蛋白2抗体

Quantity size:

0.2ml

Concentration:

1mg/ml L型氨基酸转运蛋白2抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

L-amino acid transporter protein-2 (LAT2), a non-glycosylated membrane protein, complexes with CD98 to contribute to readsorption of neutral amino acids in renal epithelia and blood-tissue barriers. The gene encoding LAT2 is expressed primarily in the kidney, but also to a lesser extent in placenta, brain, liver, spleen, skeletal muscle, heart, smallL型氨基酸转运蛋白2抗体 intestine, and lung. Transfection with the antisense sequence of LAT2 suggests that LAT2 expression plays a major role in net basolateral efflux of cysteine, and points to LAT2 as a candidate gene to modulate cysteine reabsorption. In addition, the CD98/LAT2 heterodimer associates with Integrin ∫1 in intestinal epithelial cells, where ligand binding to CD98 and another cell surface molecule, ICAM-1 differentially regulates LAT2 activity, suggesting a novel mechanism by which events like cell adhesion may affect amino acid transport activity.

L型氨基酸转运蛋白2抗体Also known as:

hLAT2; integral membrane protein E16H; L type amino acid transporter 2; L-type amino acid transporter 2; Large neutral amino acids transporter small subunit 2; LAT2_HUMAN; LPI PC1; SLC7A8; solute carrier family 7 (amino acid transporter light chain, L system), member 8; solute carrier family 7 (amino acid transporter, L type), member 8; solute carrier family 7 (cationic amino acid transporter, y+ system), member 8; Solute carrier family 7 member 8.

Specificity:

●

Rabbit Polyclonal IgG, L型氨基酸转运蛋白2抗体affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Pig, Horse, Sheep, Orangutan.

●

Immunogen: KLH conjugated synthetic peptide derived from human LAT2.

●

Predicted Molecular Weight: 61kDa.

L型氨基酸转运蛋白2抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl102Mu01基质金属蛋白酶7(MMP7)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 7 (MMP7)

kl102Ra01基质金属蛋白酶7(MMP7)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 7 (MMP7)

kl103Gu01基质金属蛋白酶8(MMP8)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 8 (MMP8)

kl103Hu01基质金属蛋白酶8(MMP8)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 8 (MMP8)

kl103Mu01基质金属蛋白酶8(MMP8)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 8 (MMP8)

kl103Ra01基质金属蛋白酶8(MMP8)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 8 (MMP8)

kl104Bo01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)

kl104Ca01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)

kl104Ga01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)

kl104Gu01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)

kl104Hu01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)

kl104Mu01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)

kl104Ra01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)

kl104Rb51胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)

kl105Bo01神经生长因子(NGF)多克隆抗体Polyclonal Antibody to Nerve Growth Factor (NGF)

kl105Ga01神经生长因子(NGF)多克隆抗体Polyclonal Antibody to Nerve Growth Factor (NGF)

kl105Gu01神经生长因子(NGF)多克隆抗体Polyclonal Antibody to Nerve Growth Factor (NGF)

kl105Hu01神经生长因子(NGF)多克隆抗体Polyclonal Antibody to Nerve Growth Factor (NGF)

kl105Mu01神经生长因子(NGF)多克隆抗体Polyclonal Antibody to Nerve Growth Factor (NGF)

kl105Po01神经生长因子(NGF)多克隆抗体Polyclonal Antibody to Nerve Growth Factor (NGF)

kl105Ra01神经生长因子(NGF)多克隆抗体Polyclonal Antibody to Nerve Growth Factor (NGF)

kl105Si01神经生长因子(NGF)多克隆抗体Polyclonal Antibody to Nerve Growth Factor (NGF)

kl106Bo01神经营养因子3(NT3)多克隆抗体Polyclonal Antibody to Neurotrophin 3 (NT3)

kl106Ga01神经营养因子3(NT3)多克隆抗体Polyclonal Antibody to Neurotrophin 3 (NT3)